Delivery Order SPE2DB20D2001-SPE2DB21FM43F
- Not listed
- This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $8,352.60 issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for a Prime Vendor Pharmaceutical Branch-Philadelphia, with an ultimate completion date of April 23, 2021. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
- This federal contract award is for a Delivery Order worth $4,734.72 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for "PRIME VENDOR PHARM BRANCH-PHILADELPHIA". The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 18, 2021. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,110.52 delivery order contract is for a "Prime Vendor Pharm Branch-Philadelphia" and has a completion date of May 17, 2021. The contract is a firm fixed-price, open competition award without any set-aside designation. It is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to...
- This federal contract award is for a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,579.24, is for "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" and has a completion date of September 21, 2020. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award, valued at $1,023.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for a Prime Vendor Pharmaceutical Branch in Philadelphia, with a period of performance ending on September 3, 2020. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora, Inc. This $999,999,999 IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999. The award, with a ceiling value of $32,804.38, is for the Prime Vendor Pharmaceutical Branch in Philadelphia, encompassing a broad range of pharmaceutical products and medical supplies to support military and veteran healthcare programs. The contract...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,532.58, is a delivery order for a "Prime Vendor Pharm Branch-Philadelphia," indicating the supply of pharmaceutical products and medical supplies. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide a Prime Vendor Pharmaceutical Branch-Philadelphia. The contract is a Delivery Order valued at $31,279.75 with a firm fixed price. It has an ultimate completion date of September 25, 2020. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support...
- This federal contract award is a delivery order valued at $1,643.52 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for a Prime Vendor Pharmaceutical Branch in Philadelphia and does not have a set-aside designation, indicating open competition. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,206.57 delivery order is for the Prime Vendor Pharmacy Branch in Philadelphia, with a completion date of March 1, 2021. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB21FM43FDelivery Order
This federal contract award is a delivery order valued at $34,010.64, issued to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The order is for a Prime Vendor Pharmaceutical Branch in Philadelphia, with an ultimate completion date of March 31, 2021. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical medical commodities, to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.0k | 3/30/21 |